Alivus Life Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/05/2026 ,inter alia, to consider and approve the Audited Financial Results of the Company for the quarter and year ended 31st March, 2026 and to consider and recommend dividend, if any, on Equity shares for the year ended March 31, 2026.